Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

REVENUES, NET (Tables)

12 Months Ended

Dec. 31, 2021

Revenues by category were as follows (in thousands):

The following table summarizes the revenue allowance and accrual activities for the years ended December 31, 2021 and 2020 (in thousands):

	Trade Discounts, Allowances and Chargebacks			Government Rebates and Other Incentives			Returns			Total
Balance as of December 31, 2019	$	228		$	1,354		$	315			1,897
Provision related to sales in the current year		2,686			3,752			245			6,683
Adjustments related to prior period sales		16			(44	)		(87	)		(115	)
Credit and payments made		(2,796	)		(2,943	)		—			(5,739	)
Balance as of December 31, 2020		134			2,119			473			2,726
Provision related to sales in the current year		3,065			3,845			234			7,144
Adjustments related to prior period sales		13			226			(148	)		91
Credit and payments made		(1,731	)		(3,057	)		(20	)		(4,808	)
Balance as of December 31, 2021	$	1,481		$	3,133		$	539		$	5,153

The following table sets forth information regarding customers that accounted for 10% or more of net revenues:

	Revenue for year ended December 31,
	2021			2020
Customer A		50	%		60	%
Customer B		29	%		20	%
Customer C		10	%		8	%